APO Research
Talk to an analyst

APO RESEARCH · REPORT

DPT Series Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global DPT Series Vaccine Industry Growth and Trends Forecast to 2032

28 December 2025106 pages

Choose your research edition.

Industry ResearchDPT Series Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal DPT Series Vaccine Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal DPT Series Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DPT Series Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal DPT Series Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global DPT Series Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for DPT Series Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for DPT Series Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DPT Series Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of DPT Series Vaccine include AJ Vaccines, GSK, Panacea Biotec, Sanofi, Hualan Biological Vaccine, BioKangtai, CanSino Biologics, Walvax Biotechnology and CNBG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global DPT Series Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The DPT Series Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global DPT Series Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to DPT Series Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global DPT Series Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

DPT Series Vaccine Market by Company

AJ Vaccines

GSK

Panacea Biotec

Sanofi

Hualan Biological Vaccine

BioKangtai

CanSino Biologics

Walvax Biotechnology

CNBG

Chongqing Zhifei Biological Products

DPT Series Vaccine Segment by Type

Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine

Absorbed Tetanus Vaccine

Absorbed Diphtheria-Tetanus Combined Vaccine

DTP-IPV-Hib Pentavalent Vaccine

DTP-Hib Quadruple Vaccine

DPT Series Vaccine Segment by Application

Adults

Children

DPT Series Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Series Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DPT Series Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Series Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DPT Series Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of DPT Series Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine Table 2. Major Company of Absorbed Tetanus Vaccine Table 3. Major Company of Absorbed Diphtheria-Tetanus Combined Vaccine Table 4. Major Company of DTP-IPV-Hib Pentavalent Vaccine Table 5. Major Company of DTP-Hib Quadruple Vaccine Table 6. Global DPT Series Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global DPT Series Vaccine Sales by Type (2021-2026) & (K Units) Table 8. Global DPT Series Vaccine Sales Market Share in Volume by Type (2021-2026) Table 9. Global DPT Series Vaccine Sales by Type (2021-2026) & (US$ Million) Table 10. Global DPT Series Vaccine Sales Market Share in Value by Type (2021-2026) Table 11. Global DPT Series Vaccine Price by Type (2021-2026) & (US$/Unit) Table 12. Global DPT Series Vaccine Sales by Type (2027-2032) & (K Units) Table 13. Global DPT Series Vaccine Sales Market Share in Volume by Type (2027-2032) Table 14. Global DPT Series Vaccine Sales by Type (2027-2032) & (US$ Million) Table 15. Global DPT Series Vaccine Sales Market Share in Value by Type (2027-2032) Table 16. Global DPT Series Vaccine Price by Type (2027-2032) & (US$/Unit) Table 17. North America DPT Series Vaccine Sales by Type (2021-2026) & (K Units) Table 18. North America DPT Series Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Europe DPT Series Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Europe DPT Series Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific DPT Series Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific DPT Series Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America DPT Series Vaccine Sales by Type (2021-2026) & (K Units) Table 24. Latin America DPT Series Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa DPT Series Vaccine Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa DPT Series Vaccine Sales by Type (2021-2026) & (US$ Million) Table 27. DPT Series Vaccine Industry Trends Table 28. DPT Series Vaccine Industry Drivers Table 29. DPT Series Vaccine Industry Opportunities and Challenges Table 30. DPT Series Vaccine Industry Restraints Table 31. Global DPT Series Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global DPT Series Vaccine Revenue Market Share by Company (2021-2026) Table 33. Global DPT Series Vaccine Sales by Company (2021-2026) & (K Units) Table 34. Global DPT Series Vaccine Sales Share by Company (2021-2026) Table 35. Global DPT Series Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global DPT Series Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global DPT Series Vaccine Major Company Production Sites and Headquarters Table 38. Global DPT Series Vaccine Company, Product Type & Application Table 39. Global DPT Series Vaccine Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global DPT Series Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global DPT Series Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global DPT Series Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global DPT Series Vaccine Sales Market Share in Volume by Region (2021-2026) Table 45. Global DPT Series Vaccine Sales by Region (2021-2026) & (US$ Million) Table 46. Global DPT Series Vaccine Sales Market Share in Value by Region (2021-2026) Table 47. Global DPT Series Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global DPT Series Vaccine Sales by Region (2027-2032) & (K Units) Table 49. Global DPT Series Vaccine Sales Market Share in Volume by Region (2027-2032) Table 50. Global DPT Series Vaccine Sales by Region (2027-2032) & (US$ Million) Table 51. Global DPT Series Vaccine Sales Market Share in Value by Region (2027-2032) Table 52. Global DPT Series Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global DPT Series Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global DPT Series Vaccine Sales by Application (2021-2026) & (K Units) Table 55. Global DPT Series Vaccine Sales Market Share in Volume by Application (2021-2026) Table 56. Global DPT Series Vaccine Sales by Application (2021-2026) & (US$ Million) Table 57. Global DPT Series Vaccine Sales Market Share in Value by Application (2021-2026) Table 58. Global DPT Series Vaccine Price by Application (2021-2026) & (US$/Unit) Table 59. Global DPT Series Vaccine Sales by Application (2027-2032) & (K Units) Table 60. Global DPT Series Vaccine Sales Market Share in Volume by Application (2027-2032) Table 61. Global DPT Series Vaccine Sales by Application (2027-2032) & (US$ Million) Table 62. Global DPT Series Vaccine Sales Market Share in Value by Application (2027-2032) Table 63. Global DPT Series Vaccine Price by Application (2027-2032) & (US$/Unit) Table 64. North America DPT Series Vaccine Sales by Application (2021-2026) & (K Units) Table 65. North America DPT Series Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Europe DPT Series Vaccine Sales by Application (2021-2026) & (K Units) Table 67. Europe DPT Series Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific DPT Series Vaccine Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific DPT Series Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America DPT Series Vaccine Sales by Application (2021-2026) & (K Units) Table 71. Latin America DPT Series Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa DPT Series Vaccine Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa DPT Series Vaccine Sales by Application (2021-2026) & (US$ Million) Table 74. AJ Vaccines Company Information Table 75. AJ Vaccines Business Overview Table 76. AJ Vaccines DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. AJ Vaccines DPT Series Vaccine Product Portfolio Table 78. AJ Vaccines Recent Development Table 79. GSK Company Information Table 80. GSK Business Overview Table 81. GSK DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. GSK DPT Series Vaccine Product Portfolio Table 83. GSK Recent Development Table 84. Panacea Biotec Company Information Table 85. Panacea Biotec Business Overview Table 86. Panacea Biotec DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Panacea Biotec DPT Series Vaccine Product Portfolio Table 88. Panacea Biotec Recent Development Table 89. Sanofi Company Information Table 90. Sanofi Business Overview Table 91. Sanofi DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Sanofi DPT Series Vaccine Product Portfolio Table 93. Sanofi Recent Development Table 94. Hualan Biological Vaccine Company Information Table 95. Hualan Biological Vaccine Business Overview Table 96. Hualan Biological Vaccine DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hualan Biological Vaccine DPT Series Vaccine Product Portfolio Table 98. Hualan Biological Vaccine Recent Development Table 99. BioKangtai Company Information Table 100. BioKangtai Business Overview Table 101. BioKangtai DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. BioKangtai DPT Series Vaccine Product Portfolio Table 103. BioKangtai Recent Development Table 104. CanSino Biologics Company Information Table 105. CanSino Biologics Business Overview Table 106. CanSino Biologics DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. CanSino Biologics DPT Series Vaccine Product Portfolio Table 108. CanSino Biologics Recent Development Table 109. Walvax Biotechnology Company Information Table 110. Walvax Biotechnology Business Overview Table 111. Walvax Biotechnology DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Walvax Biotechnology DPT Series Vaccine Product Portfolio Table 113. Walvax Biotechnology Recent Development Table 114. CNBG Company Information Table 115. CNBG Business Overview Table 116. CNBG DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. CNBG DPT Series Vaccine Product Portfolio Table 118. CNBG Recent Development Table 119. Chongqing Zhifei Biological Products Company Information Table 120. Chongqing Zhifei Biological Products Business Overview Table 121. Chongqing Zhifei Biological Products DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Chongqing Zhifei Biological Products DPT Series Vaccine Product Portfolio Table 123. Chongqing Zhifei Biological Products Recent Development Table 124. North America DPT Series Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. North America DPT Series Vaccine Sales by Country (2021-2026) & (K Units) Table 126. North America DPT Series Vaccine Sales Market Share by Country (2021-2026) Table 127. North America DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 128. North America DPT Series Vaccine Sales Market Share Forecast by Country (2027-2032) Table 129. North America DPT Series Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America DPT Series Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 131. North America DPT Series Vaccine Market Share by Country (2021-2026) Table 132. North America DPT Series Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America DPT Series Vaccine Market Share Forecast by Country (2027-2032) Table 134. Europe DPT Series Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Europe DPT Series Vaccine Sales by Country (2021-2026) & (K Units) Table 136. Europe DPT Series Vaccine Sales Market Share by Country (2021-2026) Table 137. Europe DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 138. Europe DPT Series Vaccine Sales Market Share Forecast by Country (2027-2032) Table 139. Europe DPT Series Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe DPT Series Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe DPT Series Vaccine Market Share by Country (2021-2026) Table 142. Europe DPT Series Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe DPT Series Vaccine Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific DPT Series Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific DPT Series Vaccine Sales by Country (2021-2026) & (K Units) Table 146. Asia-Pacific DPT Series Vaccine Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 148. Asia-Pacific DPT Series Vaccine Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific DPT Series Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific DPT Series Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific DPT Series Vaccine Market Share by Country (2021-2026) Table 152. Asia-Pacific DPT Series Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific DPT Series Vaccine Market Share Forecast by Country (2027-2032) Table 154. Latin America DPT Series Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Latin America DPT Series Vaccine Sales by Country (2021-2026) & (K Units) Table 156. Latin America DPT Series Vaccine Sales Market Share by Country (2021-2026) Table 157. Latin America DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 158. Latin America DPT Series Vaccine Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America DPT Series Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America DPT Series Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America DPT Series Vaccine Market Share by Country (2021-2026) Table 162. Latin America DPT Series Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America DPT Series Vaccine Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa DPT Series Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa DPT Series Vaccine Sales by Country (2021-2026) & (K Units) Table 166. Middle East and Africa DPT Series Vaccine Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 168. Middle East and Africa DPT Series Vaccine Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa DPT Series Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa DPT Series Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa DPT Series Vaccine Market Share by Country (2021-2026) Table 172. Middle East and Africa DPT Series Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa DPT Series Vaccine Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. DPT Series Vaccine Distributors List Table 177. DPT Series Vaccine Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. DPT Series Vaccine Image Figure 2. Global DPT Series Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DPT Series Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global DPT Series Vaccine Sales (2021-2032) & (K Units) Figure 5. Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine Image Figure 6. Global Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Absorbed Tetanus Vaccine Image Figure 8. Global Absorbed Tetanus Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Absorbed Diphtheria-Tetanus Combined Vaccine Image Figure 10. Global Absorbed Diphtheria-Tetanus Combined Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 11. DTP-IPV-Hib Pentavalent Vaccine Image Figure 12. Global DTP-IPV-Hib Pentavalent Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 13. DTP-Hib Quadruple Vaccine Image Figure 14. Global DTP-Hib Quadruple Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global DPT Series Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global DPT Series Vaccine Market Share by Type 2025 VS 2032 Figure 17. North America DPT Series Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. North America DPT Series Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Europe DPT Series Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Europe DPT Series Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific DPT Series Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific DPT Series Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Latin America DPT Series Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Latin America DPT Series Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa DPT Series Vaccine Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa DPT Series Vaccine Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 DPT Series Vaccine Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Adults Image Figure 30. Global Adults Sales YoY Growth (2021-2032) & (K Units) Figure 31. Children Image Figure 32. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global DPT Series Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global DPT Series Vaccine Market Share by Application 2025 VS 2032 Figure 35. North America DPT Series Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. North America DPT Series Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Europe DPT Series Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Europe DPT Series Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific DPT Series Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific DPT Series Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Latin America DPT Series Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America DPT Series Vaccine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa DPT Series Vaccine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa DPT Series Vaccine Sales Market Share in Value by Application in 2025 Figure 45. North America DPT Series Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America DPT Series Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America DPT Series Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America DPT Series Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe DPT Series Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe DPT Series Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe DPT Series Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe DPT Series Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific DPT Series Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific DPT Series Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific DPT Series Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific DPT Series Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America DPT Series Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America DPT Series Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America DPT Series Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America DPT Series Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa DPT Series Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa DPT Series Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa DPT Series Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa DPT Series Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. DPT Series Vaccine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. DPT Series Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
  • Absorbed Tetanus Vaccine
  • Absorbed Diphtheria-Tetanus Combined Vaccine
  • DTP-IPV-Hib Pentavalent Vaccine
  • DTP-Hib Quadruple Vaccine
Applications
  • Adults
  • Children
Companies covered
  • AJ Vaccines
  • GSK
  • Panacea Biotec
  • Sanofi
  • Hualan Biological Vaccine
  • BioKangtai
  • CanSino Biologics
  • Walvax Biotechnology
  • CNBG
  • Chongqing Zhifei Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DPT Series Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global DPT Series Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 DPT Series Vaccine Market by Type
  6. 1.3.1 Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
  7. 1.3.2 Absorbed Tetanus Vaccine
  8. 1.3.3 Absorbed Diphtheria-Tetanus Combined Vaccine
  9. 1.3.4 DTP-IPV-Hib Pentavalent Vaccine
  10. 1.3.5 DTP-Hib Quadruple Vaccine
  11. 1.4 Global DPT Series Vaccine Market Size by Type
  12. 1.4.1 Global DPT Series Vaccine Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global DPT Series Vaccine Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global DPT Series Vaccine Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America DPT Series Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe DPT Series Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific DPT Series Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America DPT Series Vaccine Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa DPT Series Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 DPT Series Vaccine Industry Trends
  2. 2.2 DPT Series Vaccine Industry Drivers
  3. 2.3 DPT Series Vaccine Industry Opportunities and Challenges
  4. 2.4 DPT Series Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by DPT Series Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by DPT Series Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by DPT Series Vaccine Price (2021-2026)
  4. 3.4 Global DPT Series Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global DPT Series Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global DPT Series Vaccine Company, Product Type & Application
  7. 3.7 Global DPT Series Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global DPT Series Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 DPT Series Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 DPT Series Vaccine Tier 1, Tier 2, and Tier 3
4 DPT Series Vaccine Regional Status and Outlook
  1. 4.1 Global DPT Series Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global DPT Series Vaccine Historic Market Size by Region
  3. 4.2.1 Global DPT Series Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global DPT Series Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global DPT Series Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global DPT Series Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global DPT Series Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global DPT Series Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global DPT Series Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 DPT Series Vaccine by Application
  1. 5.1 DPT Series Vaccine Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global DPT Series Vaccine Market Size by Application
  5. 5.2.1 Global DPT Series Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global DPT Series Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global DPT Series Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America DPT Series Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe DPT Series Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific DPT Series Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America DPT Series Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa DPT Series Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AJ Vaccines
  2. 6.1.1 AJ Vaccines Company Information
  3. 6.1.2 AJ Vaccines Business Overview
  4. 6.1.3 AJ Vaccines DPT Series Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AJ Vaccines DPT Series Vaccine Product Portfolio
  6. 6.1.5 AJ Vaccines Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK DPT Series Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK DPT Series Vaccine Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Panacea Biotec
  14. 6.3.1 Panacea Biotec Company Information
  15. 6.3.2 Panacea Biotec Business Overview
  16. 6.3.3 Panacea Biotec DPT Series Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Panacea Biotec DPT Series Vaccine Product Portfolio
  18. 6.3.5 Panacea Biotec Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi DPT Series Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi DPT Series Vaccine Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Hualan Biological Vaccine
  26. 6.5.1 Hualan Biological Vaccine Company Information
  27. 6.5.2 Hualan Biological Vaccine Business Overview
  28. 6.5.3 Hualan Biological Vaccine DPT Series Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hualan Biological Vaccine DPT Series Vaccine Product Portfolio
  30. 6.5.5 Hualan Biological Vaccine Recent Developments
  31. 6.6 BioKangtai
  32. 6.6.1 BioKangtai Company Information
  33. 6.6.2 BioKangtai Business Overview
  34. 6.6.3 BioKangtai DPT Series Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 BioKangtai DPT Series Vaccine Product Portfolio
  36. 6.6.5 BioKangtai Recent Developments
  37. 6.7 CanSino Biologics
  38. 6.7.1 CanSino Biologics Company Information
  39. 6.7.2 CanSino Biologics Business Overview
  40. 6.7.3 CanSino Biologics DPT Series Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CanSino Biologics DPT Series Vaccine Product Portfolio
  42. 6.7.5 CanSino Biologics Recent Developments
  43. 6.8 Walvax Biotechnology
  44. 6.8.1 Walvax Biotechnology Company Information
  45. 6.8.2 Walvax Biotechnology Business Overview
  46. 6.8.3 Walvax Biotechnology DPT Series Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Walvax Biotechnology DPT Series Vaccine Product Portfolio
  48. 6.8.5 Walvax Biotechnology Recent Developments
  49. 6.9 CNBG
  50. 6.9.1 CNBG Company Information
  51. 6.9.2 CNBG Business Overview
  52. 6.9.3 CNBG DPT Series Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CNBG DPT Series Vaccine Product Portfolio
  54. 6.9.5 CNBG Recent Developments
  55. 6.10 Chongqing Zhifei Biological Products
  56. 6.10.1 Chongqing Zhifei Biological Products Company Information
  57. 6.10.2 Chongqing Zhifei Biological Products Business Overview
  58. 6.10.3 Chongqing Zhifei Biological Products DPT Series Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chongqing Zhifei Biological Products DPT Series Vaccine Product Portfolio
  60. 6.10.5 Chongqing Zhifei Biological Products Recent Developments
7 North America by Country
  1. 7.1 North America DPT Series Vaccine Sales by Country
  2. 7.1.1 North America DPT Series Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America DPT Series Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America DPT Series Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America DPT Series Vaccine Market Size by Country
  6. 7.2.1 North America DPT Series Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America DPT Series Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America DPT Series Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe DPT Series Vaccine Sales by Country
  2. 8.1.1 Europe DPT Series Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe DPT Series Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe DPT Series Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe DPT Series Vaccine Market Size by Country
  6. 8.2.1 Europe DPT Series Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe DPT Series Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe DPT Series Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific DPT Series Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific DPT Series Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific DPT Series Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific DPT Series Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific DPT Series Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific DPT Series Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific DPT Series Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific DPT Series Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America DPT Series Vaccine Sales by Country
  2. 10.1.1 South America DPT Series Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America DPT Series Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America DPT Series Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America DPT Series Vaccine Market Size by Country
  6. 10.2.1 South America DPT Series Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America DPT Series Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America DPT Series Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa DPT Series Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa DPT Series Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa DPT Series Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa DPT Series Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa DPT Series Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa DPT Series Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa DPT Series Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa DPT Series Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 DPT Series Vaccine Value Chain Analysis
  2. 12.1.1 DPT Series Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 DPT Series Vaccine Production Mode & Process
  7. 12.2 DPT Series Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 DPT Series Vaccine Distributors
  10. 12.2.3 DPT Series Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst